免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

TAP2D

K 號:K252649 · 2026-02-02

決定日期2026-02-02
產品代碼IZF
諮詢委員會RA
決定相當於

器材摘要

TAP2D is the device name listed in this FDA 510(k) record. The listed applicant is Nano-X Imaging , Ltd.. It received FDA 510(k) clearance on 2026-02-02 under 510(k) number K252649. The device is classified under product code IZF. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the TAP2D?

TAP2D is a medical device that received FDA 510(k) clearance on 2026-02-02. The listed applicant is Nano-X Imaging , Ltd.. The 510(k) number is K252649.

When did TAP2D receive FDA 510(k) clearance?

TAP2D received FDA 510(k) clearance on 2026-02-02, under 510(k) number K252649.

Who is the listed applicant for TAP2D?

The FDA 510(k) record lists Nano-X Imaging , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TAP2D?

The FDA product code for TAP2D is IZF.

其他以 Nano-X Imaging , Ltd. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:IZF)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑